Phase I study of a fifteen-day schedule of oral topotecan in hematological malignancies

Phase I study of a fifteen-day schedule of oral topotecan in hematological malignancies / M. Beran, J. Cortes, S. Obrien, D. Thomas, F. Onida, E. Estey, H.M. Kantarjian. - In: American society of clinical oncology. Program / proceedings. - ISSN 1081-0641. - 21:(2002 May), pp. 86b-86b. ((Intervento presentato al 38. convegno ASCO Annual Meeting tenutosi a Orlando (Florida) nel 2002.